News
ORLANDO, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on ...
as a common venue for discrimination against people using methadone or buprenorphine. The current system “wreaks havoc” on people seeking recovery from opioid addiction, said Sally Friedman ...
Allergic contact dermatitis (ACD) from a TTS is relatively rare. ACD is a type IV cell-mediated hypersensitivity reaction that presents with bright red erythema, indurated papules, vesicles, and ...
Astronomers have detected the most promising signs yet of a possible biosignature outside the solar system, although they remain cautious. Astronomers have detected the most promising signs yet of ...
A new augmented reality system splits the difference, by precisely guiding the hands of human carpenters. Developed by Andrea Settimi and colleagues at Switzerland's EPFL university, the open ...
A wearable system designed to assist navigation for blind and partially sighted people is presented in a study published in Nature Machine Intelligence. This system uses artificial intelligence (AI) ...
Nutriband's partnership with Kindeva Drug Delivery is focused on developing AVERSA™ Fentanyl, which integrates the AVERSA™ technology into an FDA-approved transdermal fentanyl patch system. This ...
ORLANDO, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today ...
which incorporates Nutriband's AVERSA™ abuse-deterrent transdermal technology into Kindeva's FDA-approved transdermal fentanyl patch system. AVERSA Fentanyl has the potential to be the world's first ...
In terms of value, The Global Buprenorphine Market size was valued at USD 7.28 billion in 2025, is on a trajectory of rapid expansion, with projections indicating it will soar to USD 19.25 billion by ...
Teriparatide is being investigated for use in a transdermal microneedle patch. This medication has historically been delivered by daily subcutaneous injection to treat osteoporosis. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results